Solventum Corporation (SOLV)

$73.22 +1.49 (2.08%)
Market Cap 12.41B
Revenue (ttm) 8.25B
Net Income (ttm) 478.00M
EPS (ttm) N/A
PE Ratio 13.07
Forward PE 12.79
Profit Margin 5.79%
Debt to Equity Ratio 2.43
Volume 849,500
Avg Vol 819,068
Day's Range N/A - N/A
Shares Out 173.01M
Stochastic %K 61%
Beta 0.53
Analysts Sell
Price Target $85.50

Company Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature m...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 651 733 1110
Address:
3M Center, Building 275-6W-20 2510 Conway Avenue East St. Paul, Maplewood, United States
teksviler
teksviler Jul. 18 at 8:29 PM
$SOLV $PWR $VST $RBRK Life is good 😊
0 · Reply
stockpicker63
stockpicker63 Jul. 15 at 1:57 PM
Watch today! $CRC, $APG , $SOLV and $ETN
0 · Reply
JarvisFlow
JarvisFlow Jul. 15 at 1:01 PM
Morgan Stanley has updated their rating for Solventum ( $SOLV ) to Overweight with a price target of 103.
0 · Reply
michaeljohn1919
michaeljohn1919 Jul. 14 at 10:35 PM
$SOLV quiet before the storm?!⛈️
0 · Reply
JarvisFlow
JarvisFlow Jul. 1 at 2:22 PM
Argus Research has updated their rating for Solventum ( $SOLV ) to Buy.
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 25 at 8:39 PM
Solventum $SOLV renegotiates Thermo Fisher deal - $4B sale now excludes Water Business. EPS accretion rises to 15-20¢, but margin gains take a hit. Faster close could help debt paydown, but that retained H2O biz better not spring a leak. Q2 call will reveal if this is a liquidity lifeline or just treading water. https://www.sec.gov/Archives/edgar/data/1964738/000196473825000056/solv-20250625.htm
0 · Reply
swingingtech
swingingtech Jun. 11 at 8:18 AM
$SOLV https://wallstreetwaves.com/analyst-update-solv-assigned-sector-weight-rating/
0 · Reply
ZacksResearch
ZacksResearch Jun. 3 at 4:41 PM
$SOLV just flipped the script — is the turnaround real? Q1 beat + raised guidance = bullish momentum, and the transformation is moving fast even with tariff risks in play. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2483554/solvs-strong-q1-signals-turnaround-is-the-stock-worth-betting-now?cid=sm-stocktwits-2-2483554-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2483554_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 3 at 2:33 PM
$SOLV beats Q1 expectations — but should investors hold back? 🤔 📈 EPS of $1.34 topped consensus by 12.6%, with a 4.3% organic sales boost. 🚧 Tariff headwinds could hit EPS by 35 to 45 cents in H2, squeezing margins. Hold your position and check out the full analysis here 👉 https://www.zacks.com/commentary/2483554/solvs-strong-q1-signals-turnaround-is-the-stock-worth-betting-now?cid=sm-stocktwits-2-2483554-body&ADID=SYND_STOCKTWITS_TWEET_2_2483554_BODY
0 · Reply
JarvisFlow
JarvisFlow May. 19 at 5:51 PM
Piper Sandler has updated their rating for Solventum ( $SOLV ) to Overweight with a price target of 87.
0 · Reply
Latest News on SOLV
Solventum: Appealing Again

Jul 22, 2025, 9:12 AM EDT - 14 days ago

Solventum: Appealing Again

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

Jul 17, 2025, 4:05 PM EDT - 18 days ago

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

Solventum Named a Best Company to Work for by U.S. News & World Report

Jun 18, 2025, 10:00 AM EDT - 6 weeks ago

Solventum Named a Best Company to Work for by U.S. News & World Report

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

Jun 3, 2025, 4:05 PM EDT - 2 months ago

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript

May 11, 2025, 5:07 PM EDT - 3 months ago

Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript

Solventum Corporation: Cheap, With Caveats

May 9, 2025, 11:02 AM EDT - 3 months ago

Solventum Corporation: Cheap, With Caveats

Solventum beats first-quarter profit estimates on strong surgical product sales

May 8, 2025, 6:11 PM EDT - 3 months ago

Solventum beats first-quarter profit estimates on strong surgical product sales

Solventum to Participate in the 2025 BofA Securities Health Care Conference

May 8, 2025, 4:05 PM EDT - 3 months ago

Solventum to Participate in the 2025 BofA Securities Health Care Conference

Solventum Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 3 months ago

Solventum Reports First Quarter 2025 Financial Results

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025

Apr 17, 2025, 4:05 PM EDT - 3 months ago

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

Mar 25, 2025, 6:00 PM EDT - 4 months ago

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy

Mar 21, 2025, 12:44 PM EDT - 4 months ago

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy

Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Mar 20, 2025, 9:00 AM EDT - 4 months ago

Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

Mar 12, 2025, 8:12 AM EDT - 5 months ago

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 8:36 AM EST - 5 months ago

Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript

Solventum forecasts annual profit above estimates on strong surgical product sales

Feb 27, 2025, 5:09 PM EST - 5 months ago

Solventum forecasts annual profit above estimates on strong surgical product sales

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Feb 27, 2025, 4:05 PM EST - 5 months ago

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Feb 26, 2025, 4:15 PM EST - 5 months ago

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports

Feb 26, 2025, 3:37 PM EST - 5 months ago

Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports

Trian Comments on Solventum's Sale of its Purification & Filtration Business

Feb 26, 2025, 2:50 PM EST - 5 months ago

Trian Comments on Solventum's Sale of its Purification & Filtration Business

TMO

Solventum In The Early Stages Of A Multiyear Turnaround Effort

Feb 25, 2025, 10:16 AM EST - 5 months ago

Solventum In The Early Stages Of A Multiyear Turnaround Effort

Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion

Feb 25, 2025, 8:56 AM EST - 5 months ago

Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion

TMO

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

Feb 25, 2025, 8:39 AM EST - 5 months ago

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

TMO

Thermo Fisher Scientific to Acquire Solventum's Purification and Filtration Business

Feb 25, 2025, 8:32 AM EST - 5 months ago

Thermo Fisher Scientific to Acquire Solventum's Purification and Filtration Business

TMO

Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

Feb 11, 2025, 8:00 AM EST - 6 months ago

Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging

Feb 5, 2025, 10:00 AM EST - 6 months ago

Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging

Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025

Jan 30, 2025, 4:05 PM EST - 6 months ago

Solventum to Report Fourth Quarter and Full Year Fiscal 2024 Earnings on February 27, 2025

Peltz's Trian Fund says 3M's Solventum spin-off not living up to potential

Jan 8, 2025, 1:38 PM EST - 7 months ago

Peltz's Trian Fund says 3M's Solventum spin-off not living up to potential

Trian Issues Open Letter to Solventum Shareholders

Jan 8, 2025, 1:01 PM EST - 7 months ago

Trian Issues Open Letter to Solventum Shareholders

The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact Investing

Jan 8, 2025, 6:30 AM EST - 7 months ago

The T1D Fund Appoints Industry Veteran Elizabeth Mily as CEO to Accelerate Development of Type 1 Diabetes Cures Through Impact Investing

Solventum to Participate in the Piper Sandler Healthcare Conference

Nov 19, 2024, 6:50 AM EST - 9 months ago

Solventum to Participate in the Piper Sandler Healthcare Conference

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

Nov 14, 2024, 9:00 AM EST - 9 months ago

Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 5:16 PM EST - 9 months ago

Solventum Corporation (SOLV) Q3 2024 Earnings Call Transcript

Solventum raises annual profit forecast on strong surgical product sales

Nov 7, 2024, 4:47 PM EST - 9 months ago

Solventum raises annual profit forecast on strong surgical product sales

Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance

Nov 7, 2024, 4:05 PM EST - 9 months ago

Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance

Solventum Taps Bankers to Explore Sale of Filtration Unit

Oct 24, 2024, 11:33 AM EDT - 10 months ago

Solventum Taps Bankers to Explore Sale of Filtration Unit

Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Oct 15, 2024, 6:50 AM EDT - 10 months ago

Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Solventum Announces Commitment to 100% Renewable Electricity by 2030

Oct 14, 2024, 7:00 AM EDT - 10 months ago

Solventum Announces Commitment to 100% Renewable Electricity by 2030

Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer

Oct 10, 2024, 9:00 AM EDT - 10 months ago

Solventum Names Surgeon and Diagnostics Pioneer Dr. Ryan Egeland as Chief Medical Officer

Buy 4 October Dividend Aristocrats & Watch 10

Oct 9, 2024, 12:17 PM EDT - 10 months ago

Buy 4 October Dividend Aristocrats & Watch 10

ADM AMCR BEN CVX ED FAST FRT

Buy 4 September Dividend Aristocrats And Watch 6

Sep 10, 2024, 1:25 PM EDT - 11 months ago

Buy 4 September Dividend Aristocrats And Watch 6

AMCR APD BEN CVX FAST FRT GPC

Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy

Sep 10, 2024, 6:45 AM EDT - 11 months ago

Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® Therapy

Solventum to Participate in Upcoming Investor Conferences

Aug 28, 2024, 6:50 AM EDT - 1 year ago

Solventum to Participate in Upcoming Investor Conferences

Lanny's Stock Sales Through June 30, 2024

Aug 26, 2024, 11:55 AM EDT - 1 year ago

Lanny's Stock Sales Through June 30, 2024

CIM MDU MMM PARA

Trade Tracker: Jenny Harrington sells Solventum Corp.

Aug 23, 2024, 1:16 PM EDT - 1 year ago

Trade Tracker: Jenny Harrington sells Solventum Corp.

Solventum autonomous coding listed in Epic Toolbox

Aug 20, 2024, 9:00 AM EDT - 1 year ago

Solventum autonomous coding listed in Epic Toolbox

Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 2:39 PM EDT - 1 year ago

Solventum Corporation (SOLV) Q2 2024 Earnings Call Transcript

Solventum's second-quarter profit falls 70% on higher expenses

Aug 8, 2024, 7:08 PM EDT - 1 year ago

Solventum's second-quarter profit falls 70% on higher expenses

Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Curreen Capital: Ugly Ducklings Selling At An Attractive Price

Jul 27, 2024, 10:10 PM EDT - 1 year ago

Curreen Capital: Ugly Ducklings Selling At An Attractive Price

EHAB MMM VFC

teksviler
teksviler Jul. 18 at 8:29 PM
$SOLV $PWR $VST $RBRK Life is good 😊
0 · Reply
stockpicker63
stockpicker63 Jul. 15 at 1:57 PM
Watch today! $CRC, $APG , $SOLV and $ETN
0 · Reply
JarvisFlow
JarvisFlow Jul. 15 at 1:01 PM
Morgan Stanley has updated their rating for Solventum ( $SOLV ) to Overweight with a price target of 103.
0 · Reply
michaeljohn1919
michaeljohn1919 Jul. 14 at 10:35 PM
$SOLV quiet before the storm?!⛈️
0 · Reply
JarvisFlow
JarvisFlow Jul. 1 at 2:22 PM
Argus Research has updated their rating for Solventum ( $SOLV ) to Buy.
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jun. 25 at 8:39 PM
Solventum $SOLV renegotiates Thermo Fisher deal - $4B sale now excludes Water Business. EPS accretion rises to 15-20¢, but margin gains take a hit. Faster close could help debt paydown, but that retained H2O biz better not spring a leak. Q2 call will reveal if this is a liquidity lifeline or just treading water. https://www.sec.gov/Archives/edgar/data/1964738/000196473825000056/solv-20250625.htm
0 · Reply
swingingtech
swingingtech Jun. 11 at 8:18 AM
$SOLV https://wallstreetwaves.com/analyst-update-solv-assigned-sector-weight-rating/
0 · Reply
ZacksResearch
ZacksResearch Jun. 3 at 4:41 PM
$SOLV just flipped the script — is the turnaround real? Q1 beat + raised guidance = bullish momentum, and the transformation is moving fast even with tariff risks in play. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2483554/solvs-strong-q1-signals-turnaround-is-the-stock-worth-betting-now?cid=sm-stocktwits-2-2483554-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2483554_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 3 at 2:33 PM
$SOLV beats Q1 expectations — but should investors hold back? 🤔 📈 EPS of $1.34 topped consensus by 12.6%, with a 4.3% organic sales boost. 🚧 Tariff headwinds could hit EPS by 35 to 45 cents in H2, squeezing margins. Hold your position and check out the full analysis here 👉 https://www.zacks.com/commentary/2483554/solvs-strong-q1-signals-turnaround-is-the-stock-worth-betting-now?cid=sm-stocktwits-2-2483554-body&ADID=SYND_STOCKTWITS_TWEET_2_2483554_BODY
0 · Reply
JarvisFlow
JarvisFlow May. 19 at 5:51 PM
Piper Sandler has updated their rating for Solventum ( $SOLV ) to Overweight with a price target of 87.
0 · Reply
ZacksResearch
ZacksResearch May. 9 at 1:48 PM
$SOLV's first-quarter earnings showcase strong segmental performance. However, declining margins raise concerns. Read more: https://www.zacks.com/stock/news/2466173/solventum-stock-gains-on-q1-earnings-revenue-beat-margins-decline?cid=sm-stocktwits-2-2466173-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2466173_TEASER
0 · Reply
michaeljohn1919
michaeljohn1919 May. 8 at 8:41 PM
$SOLV 🔥🔥🔥
1 · Reply
ahab
ahab May. 7 at 12:02 PM
$SOLV traded the 5/1-5/2 move, posts ER 5/8, usually beats, It's a medical spin off from 3M. 65.17 MBAC and top of shadow 4/10/25 bottom of shadows 63 ish. hand grenade down the hole= 1/2 position
0 · Reply
ahab
ahab May. 1 at 8:21 PM
$SOLV interesting
1 · Reply
michaeljohn1919
michaeljohn1919 Apr. 30 at 11:42 AM
$SOLV… May 8th!!
0 · Reply
TwitsWits
TwitsWits Apr. 26 at 4:43 PM
$SOLV it’s good to know people are still buying stock that’s poisoning our people and humanity but keep it going. Keep these companies going so they poison us some more guess what I work for these motherfuckers and they’re trying to kill me every single day and I don’t own a single fucking stock in this shit.
1 · Reply
bigbulldaddy
bigbulldaddy Apr. 7 at 1:40 PM
$SOLV this theory of mimedix getting bought by solventum might have legs. One of their senior marketers and KCI alum John Tatum just came back to Solventum.
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Mar. 28 at 8:59 PM
$SOLV Hows that due diligence going with $MDXG ?
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Mar. 22 at 2:52 AM
$SOLV Time to buy MDXG
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 3:42 PM
$SOLV Digging SOLV's healthcare innovation play. Spin-off from 3M looks interesting. Watching their ERP transition and segment performance closely. MedSurg segment seems strong. Might take a small entry if Q1 looks clean. great article: https://beyondspx.com/article/solventum-corporation-navigating-a-transformative-journey-in-healthcare-innovation
0 · Reply
GCooter
GCooter Mar. 14 at 12:49 PM
$SOLV flying today
0 · Reply
swingingtech
swingingtech Mar. 13 at 5:57 PM
$SOLV https://wallstreetwaves.com/secure-a-2-9-annualized-return-by-committing-to-purchase-solventum-at-50-with-options/
0 · Reply